通窍化栓汤联合阿替普酶治疗急性脑梗死临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R744.33

基金项目:


Clinical Study on Tongqiao Huashuan Tang Combined with Alteplase for Acute Cerebral Infarction
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察通窍化栓汤联合阿替普酶治疗急性脑梗死的疗效。方法:采用随机数字表法将88 例风痰瘀阻型急性脑梗死患者随机分为对照组和联合组各44 例。2 组均予阿替普酶溶栓治疗,溶栓治疗24 h 后,给予常规抗凝、抗血小板、减轻脑水肿等对症治疗,联合组加予通窍化栓汤治疗。2 组均治疗14 d。治疗前后评定脑神经功能状态[美国国立卫生研究院脑卒中量表(NIHSS) 评分]、日常生活能力[改良Barthel 指数(MBI) 评分]、血清炎症因子[C-反应蛋白(CRP)、白细胞介素-8(IL-8)、降钙素原(PCT)]和D-二聚体(D-D) 水平,比较2 组的临床疗效、不良反应发生率。结果:治疗14 d,联合组临床疗效总有效率高于对照组(P<0.05)。2 组NIHSS 评分均较治疗前降低,MBI 评分均较治疗前升高,差异均有统计学意义(P<0.05);联合组NIHSS 评分低于对照组,MBI 评分高于对照组,差异均有统计学意义(P<0.05)。2 组CRP、PCT、IL-8、D-D 水平均较治疗前降低(P<0.05),联合组4 项指标水平均低于对照组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:应用通窍化栓汤联合阿替普酶治疗能够提高急性脑梗死患者的临床疗效,同时能促进神经功能恢复、减轻炎症,有效改善患者的凝血功能与提高日常生活能力,且安全性较高。

    Abstract:

    Abstract: Objective: To observe the curative effect of Tongqiao Huashuan tang combined with alteplase for acute cerebral infarction. Methods:A total of 88 cases of patients with acute with wind- phlegm stasis obstruction type cerebral infarction were divided into the control group and the combination group according to the random number table method,with 44 cases in each group. Both groups were treated with alteplase thrombolysis, after 24 hours of thrombolytic therapy, symptomatic treatments were given, such as routine anticoagulation, antiplatelet and reducing brain edema, and the combination group was additionally treated with Tongqiao Huashuan tang. Both groups were treated for 14 days. Before and after treatment,brain nerve function state[National Institute of Health Stroke Scale(NIHSS) scores],activities of daily living [Modified Barthel Index(MBI) scores], serum inflammatory factors [C- reactive protein(CRP), interleukin- 8(IL- 8) and procalcitonin(PCT)] and D- Dimer(D- D) levels were assessed. Clinical effects and incidences of adverse reactions were compared between the two groups. Results:After 14 days of treatment,the total effective rate in the combination group was higher than that in the control group(P<0.05). NIHSS scores in the two groups were decreased when compared with those before treatment, and MBI scores were increased, differences being significant(P<0.05); NIHSS score in the combination group was lower than that in the control group, and MBI score was higher, differences being significant(P< 0.05). The levels of CRP, PCT, IL- 8 and D- D in the two groups were decreased when compared with those before treatment(P<0.05),and the above four levels in the combination group were lower than those in the control group(P<0.05). There was no significant difference being found in the comparison of incidences of adverse reactions between the two groups (P>0.05). Conclusion:The application of Tongqiao Huashuan tang combined with alteplase can improve the clinical effect of patients with acute cerebral infarction, and promote the recovery of neurological function, reduce the inflammation, and effectively improve the coagulation function and the activities of daily living,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

梁霄龙,金友平,戴圣纬,盖世英.通窍化栓汤联合阿替普酶治疗急性脑梗死临床研究[J].新中医,2022,54(12):81-85

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-06-22
  • 出版日期:
文章二维码